Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413296
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2006-12-18
Brief Title:
Levetiracetam in Post-Traumatic Stress Disorder
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder
Status:
COMPLETED
Status Verified Date:
2010-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PTSD
Brief Summary:
The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder PTSD and to evaluate continuation effects of levetiracetam in preventing PTSD relapse The hypothesis is that levetiracetam will be safe and effective in preventing relapse of PTSD
Detailed Description:
This is an investigator-initiated single site study consisting of two phases 8 weeks of open label treatment with levetiracetam 500-2000 mgday in patients with PTSD and in those who demonstrate at least minimal improvement 12 weeks of randomized double-blind treatment with either levetiracetam or matching placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 7031-05-4R0 | OTHER | DUMC | None |